Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: structure-activity relationship and pharmacological evaluation

European Journal of Medicinal Chemistry
Anne ThiryBernard Masereel

Abstract

A small library of indanesulfonamides was screened for the inhibition of the human carbonic anhydrase (CA, EC 4.2.1.1) isoforms involved in neuronal excitation, that is, isoforms VII, XII and XIV. These CA isoforms are becoming interesting target for the design of agents useful for the treatment of epilepsy. The inhibition pattern of these indanesulfonamide compounds towards these three isoforms was excellent, with many nanomolar inhibitors detected (K(I)s in the range of 0.78-10 nM against hCA VII; 0.32-56 nM against hCA XII, and 0.47-1030 nM against hCA XIV, respectively). The maximal electroshock seizure (MES) test performed on mice showed a good anticonvulsant activity for some compounds which protected the mice against convulsions in the 50-62.5% range at a dose of 50 mg/kg. In parallel, the blood-brain barrier passive permeation of these sulfonamides was also estimated by using a computational approach.

References

Jan 1, 1990·Stroke; a Journal of Cerebral Circulation·T V BogsrudR Nyberg-Hansen
Jan 1, 1984·Cleveland Clinic Quarterly·R J PorterB G White
May 1, 1996·The Annals of Pharmacotherapy·W G Reiss, K S Oles
Apr 18, 2000·Epilepsia·S J DodgsonB E Maryanoff
Jun 8, 2000·Journal of Medicinal Chemistry·P CrivoriB Testa
Jul 20, 2001·Epilepsy Research·M J Brodie
Dec 25, 2002·Medicinal Research Reviews·Claudiu T SupuranAngela Casini
Mar 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eva RuusuvuoriJuha Voipio
Oct 27, 2004·Bioorganic & Medicinal Chemistry Letters·Celine ChazaletteClaudiu T Supuran
Oct 30, 2004·Seizure : the Journal of the British Epilepsy Association·Ilo E Leppik
Feb 3, 2005·Bioorganic & Medicinal Chemistry Letters·Daniela VulloClaudiu T Supuran
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·William M Pardridge
Jul 26, 2005·Bioorganic & Medicinal Chemistry Letters·Isao NishimoriClaudiu T Supuran
Jan 4, 2006·Cellular and Molecular Life Sciences : CMLS·A M KaindlC Ikonomidou
Jan 18, 2006·Epilepsy Research·Michel Baulac
May 17, 2007·Current Topics in Medicinal Chemistry·Claudiu T Supuran
May 17, 2007·Current Topics in Medicinal Chemistry·Anne ThiryBernard Masereel

❮ Previous
Next ❯

Citations

May 27, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Kalyan K SethiPadilam Suresh
Jul 30, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Muhammed AlzweiriYusuf Al-Hiari
Mar 12, 2016·Progress in Neurobiology·Hanshu ZhaoZhongling Zhang
Jan 21, 2016·Chemistry : a European Journal·Bartolo GabrieleLucia Veltri
Aug 21, 2010·European Journal of Medicinal Chemistry·Rahmi KasımoğullarıBaşak Gökçe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.